title: CMV infection and allograft rejection.
authors.affiliation: Transplantation Laboratory, University of Helsinki, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Häyry
authors.forename: K
authors.initials: K
authors.lastname: Lemström
authors.forename: E
authors.initials: E
authors.lastname: von Willebrand
authors.forename: J
authors.initials: J
authors.lastname: Tikkanen
authors.forename: P
authors.initials: P
authors.lastname: Koskinen
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000150:complications*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D011183:Postoperative Complications; D051381:Rats
chemical_list: D000998:Antiviral Agents; D002121:Calcium Channel Blockers; D015774:Ganciclovir